Literature DB >> 9498637

Decreased nitric oxide synthase activity in platelets from IDDM and NIDDM patients.

R A Rabini1, R Staffolani, P Fumelli, B Mutus, G Curatola, L Mazzanti.   

Abstract

Nitric oxide (NO) produced by platelet nitric oxide synthase (NOS) inhibits platelet activation by increased cytoplasmic cGMP levels. The aim of this study was to investigate platelet NOS activity in insulin-dependent (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM), which are characterized by enhanced platelet activation. HbA1c levels, platelet NOS and platelet membrane Na+/K+ ATPase activity were determined in 19 IDDM patients, 21 NIDDM patients and 31 healthy control subjects. NOS activity was measured by a spectrophotometric method based on NO-dependent oxidation of oxyhaemoglobin to met-haemoglobin. Na+/K+ ATPase activity was measured by the method of Kitao and Hattori. Both NOS and Na+/K+ ATPase activity were significantly reduced in diabetic subjects compared with control subjects. NOS showed a significant negative relation with HbA1c levels and a positive relation with Na+/K+ ATPase activity in diabetic patients. It is hypothesized that the decreased NOS activity might play a role in the pathogenesis of diabetic vascular complications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498637     DOI: 10.1007/s001250050873

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  9 in total

1.  Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin.

Authors:  Rolf P Kreutz; Perry Nystrom; Yvonne Kreutz; Jia Miao; Richard Kovacs; Zeruesenay Desta; David A Flockhart; Yan Jin
Journal:  Platelets       Date:  2012-03-02       Impact factor: 3.862

2.  Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1.

Authors:  V Martina; G A Bruno; E Zumpano; C Origlia; L Quaranta; G P Pescarmona
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

3.  Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus.

Authors:  L R Queen; Y Ji; I Goubareva; A Ferro
Journal:  Diabetologia       Date:  2003-10-23       Impact factor: 10.122

Review 4.  Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP- and NO-dependent mechanisms in the insulin-mediated platelet aggregation.

Authors:  Tatiana E Suslova; Alexei V Sitozhevskii; Oksana N Ogurkova; Elena S Kravchenko; Irina V Kologrivova; Yana Anfinogenova; Rostislav S Karpov
Journal:  Front Physiol       Date:  2015-01-05       Impact factor: 4.566

5.  Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality.

Authors:  James J DiNicolantonio; James H O'Keefe; Mark F McCarty
Journal:  Open Heart       Date:  2017-09-02

6.  Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography.

Authors:  Benjamin T Maatman; Glen Schmeisser; Rolf P Kreutz
Journal:  J Diabetes Res       Date:  2018-02-04       Impact factor: 4.011

Review 7.  Role of the Platelets and Nitric Oxide Biotransformation in Ischemic Stroke: A Translative Review from Bench to Bedside.

Authors:  Maciej Bladowski; Jakub Gawrys; Damian Gajecki; Ewa Szahidewicz-Krupska; Anna Sawicz-Bladowska; Adrian Doroszko
Journal:  Oxid Med Cell Longev       Date:  2020-08-28       Impact factor: 6.543

8.  Increased Intraplatelet ADMA Level May Promote Platelet Activation in Diabetes Mellitus.

Authors:  Jakub Gawryś; Jerzy Wiśniewski; Ewa Szahidewicz-Krupska; Damian Gajecki; Julia Leśniewska; Filip Majda; Karolina Gawryś; Paulina Fortuna; Piotr Mlynarz; Adrian Doroszko
Journal:  Oxid Med Cell Longev       Date:  2020-09-29       Impact factor: 6.543

9.  Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats.

Authors:  James Grijalva; Steven Hicks; Xiangmin Zhao; Sushma Medikayala; Pawel M Kaminski; Michael S Wolin; John G Edwards
Journal:  Cardiovasc Diabetol       Date:  2008-11-19       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.